Table 4. Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.
| Variables | Total | Initiated treatment | % (95% CI) | Died | % (95% CI) | Lost to follow-up | % (95% CI) | Transferred Out | % (95% CI) | NA | % (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 3045 | 2738 | 89.9 (88.8–90.9) | 60 | 2.0 (1.5–2.5) | 118 | 3.9 (3.2–4.6) | 6 | 0.2 (0.1–0.5) | 123 | 4.0 (3.4–4.8) |
| Age | |||||||||||
| 0–4 | 639 | 523 | 81.9 (78.6–84.7) | 32 | 5.0 (3.6–7.0) | 39 | 6.1 (4.4–8.3) | 2 | 0.3 (0.1–1.3) | 43 | 6.7 (5.0–9.0) |
| 5–9 | 685 | 620 | 90.5 (88.0–92.6) | 13 | 2.0 (1.1–3.3) | 22 | 3.2 (2.1–4.9) | 0 | 30 | 4.4 (3.0–6.3) | |
| 10–14 | 1721 | 1595 | 92.7 (91.3–93.8) | 15 | 0.9 (0.5–1.5) | 57 | 3.3 (2.5–4.3) | 4 | 0.2 (0.1–0.6) | 50 | 2.9 (2.2–3.9) |
| Gender | |||||||||||
| Female | 1871 | 1689 | 90.3 (88.8–91.6) | 38 | 2.0 (1.5–2.8) | 69 | 3.7 (2.9–4.7) | 1 | 0.1 (0–0.03) | 74 | 4.0 (3.1–5.0) |
| Male | 1174 | 1049 | 89.4(87.4–91.0) | 22 | 1.9 (1.2–2.9) | 49 | 4.2 (3.1–5.5) | 5 | 0.4 (0.2–1.1) | 49 | 4.2 (3.1–5.5) |
| Sector | |||||||||||
| Private | 281 | 260 | 92.5 (88.6–95.2) | 11 | 3.9 (2.2–7.1) | 1 | 0.4 (0.1–2.3) | 9 | 3.2 (1.6–6.2) | ||
| Public | 2764 | 2478 | 89.7 (88.4–90.8) | 60 | 2.2 (1.7–2.8) | 107 | 3.9 (3.2–4.7) | 5 | 0.2 (0.1–0.5) | 114 | 4.1 (3.4–5.0) |
NA- not available